Alternative antigen processing for MHC class I: Multiple roads lead to Rome

Frontiers in Immunology

Volumn 6, Issue JUN, 2015, Pages

  Oliveira, Cláudia C ^a   van Hall, Thorbald ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autophagy; CD8 T cells; ER associated degradation; Peptide loading complex; T cell epitopes associated with peptide processing; Transporter associated with antigen processing; Tumor immunology

Indexed keywords

EPITOPE; FURIN; INSULINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METALLOPROTEINASE; PRESENILIN; PROTEASOME; SIGNAL PEPTIDE; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ALZHEIMER DISEASE; ANTIGEN BINDING; ANTIGEN PRESENTATION; AUTOPHAGY; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR IMMUNITY; ENZYME ACTIVITY; HOUSEKEEPING GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DIAGNOSIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SECRETORY PATHWAY; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; VIRUS INFECTION;

EID: 84935129596     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00298     Document Type: Review

References (122)

1. Hughes EA, Ortmann B, Surman M, Cresswell P. The protease inhibitor, N-acetyl-l-leucyl-l-leucyl-leucyl-l-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. J Exp Med (1996) 183(4):1569-78. doi:10.1084/jem.183.4.1569
2. Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J (2001) 20(10):2357-66. doi:10.1093/emboj/20.10.2357
3. Kisselev AF, Akopian TN, Woo KM, Goldberg AL. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J Biol Chem (1999) 274(6):3363-71. doi:10.1074/jbc.274.6.3363
4. Saric T, Chang SC, Hattori A, York IA, Markant S, Rock KL, et al. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol (2002) 3(12):1169-76. doi:10.1038/ni859
5. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature (2002) 419(6906):480-3. doi:10.1038/nature01074
6. York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol (2002) 3(12):1177-84. doi:10.1038/ni860
7. Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev (2005) 207:145-57. doi:10.1111/j.0105-2896.2005.00320.x
8. Jensen PE. Recent advances in antigen processing and presentation. Nat Immunol (2007) 8(10):1041-8. doi:10.1038/ni1516
9. Kloetzel PM, Ossendorp F. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol (2004) 16(1):76-81. doi:10.1016/j.coi.2003.11.004
10. Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol (2011) 11(12):823-36. doi:10.1038/nri3084
11. Rock KL, Farfan-Arribas DJ, Shen L. Proteases in MHC class I presentation and cross-presentation. J Immunol (2010) 184(1):9-15. doi:10.4049/jimmunol.0903399
12. Vyas JM, Van der Veen AG, Ploegh HL. The known unknowns of antigen processing and presentation. Nat Rev Immunol (2008) 8(8):607-18. doi:10.1038/nri2368
13. Geier E, Pfeifer G, Wilm M, Lucchiari-Hartz M, Baumeister W, Eichmann K, et al. A giant protease with potential to substitute for some functions of the proteasome. Science (1999) 283(5404):978-81. doi:10.1126/science.283.5404.978
14. Glas R, Bogyo M, McMaster JS, Gaczynska M, Ploegh HL. A proteolytic system that compensates for loss of proteasome function. Nature (1998) 392(6676):618-22. doi:10.1038/33443
15. Kessler JH, Khan S, Seifert U, Le Gall S, Chow KM, Paschen A, et al. Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol (2011) 12(1):45-53. doi:10.1038/ni.1974
16. Wang EW, Kessler BM, Borodovsky A, Cravatt BF, Bogyo M, Ploegh HL, et al. Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. Proc Natl Acad Sci U S A (2000) 97(18):9990-5. doi:10.1073/pnas.180328897
17. Seifert U, Maranon C, Shmueli A, Desoutter JF, Wesoloski L, Janek K, et al. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat Immunol (2003) 4(4):375-9. doi:10.1038/ni905
18. Parmentier N, Stroobant V, Colau D, de Diesbach P, Morel S, Chapiro J, et al. Production of an antigenic peptide by insulin-degrading enzyme. Nat Immunol (2010) 11(5):449-54. doi:10.1038/ni.1862
19. Reits E, Neijssen J, Herberts C, Benckhuijsen W, Janssen L, Drijfhout JW, et al. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity (2004) 20(4):495-506. doi:10.1016/S1074-7613(04)00074-3
20. Saric T, Graef CI, Goldberg AL. Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases. J Biol Chem (2004) 279(45):46723-32. doi:10.1074/jbc.M406537200
21. Urban S, Textoris-Taube K, Reimann B, Janek K, Dannenberg T, Ebstein F, et al. The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases. J Immunol (2012) 189(2):529-38. doi:10.4049/jimmunol.1101886
22. York IA, Mo AX, Lemerise K, Zeng W, Shen Y, Abraham CR, et al. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity (2003) 18(3):429-40. doi:10.1016/S1074-7613(03)00058-X
23. Johnson AE, van Waes MA. The translocon: a dynamic gateway at the ER membrane. Annu Rev Cell Dev Biol (1999) 15:799-842. doi:10.1146/annurev.cellbio.15.1.799
24. Rapoport TA, Rolls MM, Jungnickel B. Approaching the mechanism of protein transport across the ER membrane. Curr Opin Cell Biol (1996) 8(4):499-504. doi:10.1016/S0955-0674(96)80027-5
25. Martoglio B, Dobberstein B. Signal sequences: more than just greasy peptides. Trends Cell Biol (1998) 8(10):410-5. doi:10.1016/S0962-8924(98)01360-9
26. Dalbey RE, Lively MO, Bron S, van Dijl JM. The chemistry and enzymology of the type I signal peptidases. Protein Sci (1997) 6(6):1129-38. doi:10.1002/pro.5560060601
27. Weihofen A, Binns K, Lemberg MK, Ashman K, Martoglio B. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science (2002) 296(5576):2215-8. doi:10.1126/science.1070925
28. Lyko F, Martoglio B, Jungnickel B, Rapoport TA, Dobberstein B. Signal sequence processing in rough microsomes. J Biol Chem (1995) 270(34):19873-8. doi:10.1074/jbc.270.34.19873
29. Weihofen A, Lemberg MK, Ploegh HL, Bogyo M, Martoglio B. Release of signal peptide fragments into the cytosol requires cleavage in the transmembrane region by a protease activity that is specifically blocked by a novel cysteine protease inhibitor. J Biol Chem (2000) 275(40):30951-6. doi:10.1074/jbc.M005980200
30. Aldrich CJ, DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell (1994) 79(4):649-58. doi:10.1016/0092-8674(94)90550-9
31. Bland FA, Lemberg MK, McMichael AJ, Martoglio B, Braud VM. Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E. J Biol Chem (2003) 278(36):33747-52. doi:10.1074/jbc.M305593200
32. Braud V, Jones EY, McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol (1997) 27(5):1164-9. doi:10.1002/eji.1830270517
33. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol (1998) 160(10):4951-60.
34. Rodgers JR, Cook RG. MHC class Ib molecules bridge innate and acquired immunity. Nat Rev Immunol (2005) 5:459-71. doi:10.1038/nri1635
35. van Hall T, Laban S, Koppers-Lalic D, Koch J, Precup C, Asmawidjaja P, et al. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1. J Immunol (2007) 178(2):657-62. doi:10.4049/jimmunol.178.2.657
36. van Hall T, Oliveira CC, Joosten SA, Ottenhoff TH. The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stress. Microbes Infect (2010) 12(12-13):910-8. doi:10.1016/j.micinf.2010.07.011
37. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, et al. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (1992) 255:1264-6. doi:10.1126/science.1546329
38. Wei ML, Cresswell P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (1992) 356:443-6. doi:10.1038/356443a0
39. Friedmann E, Lemberg MK, Weihofen A, Dev KK, Dengler U, Rovelli G, et al. Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. J Biol Chem (2004) 279(49):50790-8. doi:10.1074/jbc.M407898200
40. Voss M, Schroder B, Fluhrer R. Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases. Biochim Biophys Acta (2013) 1828(12):2828-39. doi:10.1016/j.bbamem.2013.03.033
41. Fluhrer R, Martin L, Klier B, Haug-Kroper M, Grammer G, Nuscher B, et al. The alpha-helical content of the transmembrane domain of the British dementia protein-2 (Bri2) determines its processing by signal peptide peptidase-like 2b (SPPL2b). J Biol Chem (2012) 287(7):5156-63. doi:10.1074/jbc.M111.328104
42. Lemberg MK, Martoglio B. Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol Cell (2002) 10(4):735-44. doi:10.1016/S1097-2765(02)00655-X
43. Lemberg MK, Martoglio B. On the mechanism of SPP-catalysed intramembrane proteolysis; conformational control of peptide bond hydrolysis in the plane of the membrane. FEBS Lett (2004) 564(3):213-8. doi:10.1016/S0014-5793(04)00192-9
44. Oehler V, Filipe A, Montserret R, da Costa D, Brown G, Penin F, et al. Structural analysis of hepatitis C virus core-E1 signal peptide and requirements for cleavage of the genotype 3a signal sequence by signal peptide peptidase. J Virol (2012) 86(15):7818-28. doi:10.1128/JVI.00457-12
45. Targett-Adams P, Hope G, Boulant S, McLauchlan J. Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production. J Biol Chem (2008) 283(24):16850-9. doi:10.1074/jbc.M802273200
46. Targett-Adams P, Schaller T, Hope G, Lanford RE, Lemon SM, Martin A, et al. Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivo. J Biol Chem (2006) 281(39):29221-7. doi:10.1074/jbc.M605373200
47. Hu J, Xue Y, Lee S, Ha Y. The crystal structure of GXGD membrane protease FlaK. Nature (2011) 475(7357):528-31. doi:10.1038/nature10218
48. Li X, Dang S, Yan C, Gong X, Wang J, Shi Y. Structure of a presenilin family intramembrane aspartate protease. Nature (2013) 493(7430):56-61. doi:10.1038/nature11801
49. Nam SE, Kim AC, Paetzel M. Crystal structure of Bacillus subtilis signal peptide peptidase A. J Mol Biol (2012) 419(5):347-58. doi:10.1016/j.jmb.2012.03.020
50. Nam SE, Paetzel M. Structure of signal peptide peptidase A with C-termini bound in the active sites: insights into specificity, self-processing, and regulation. Biochemistry (2013) 52(49):8811-22. doi:10.1021/bi4011489
51. Lu P, Bai XC, Ma D, Xie T, Yan C, Sun L, et al. Three-dimensional structure of human gamma-secretase. Nature (2014) 512(7513):166-70. doi:10.1038/nature13567
52. Oliveira CC, Querido B, Sluijter M, de Groot AF, van der Zee R, Rabelink MJ, et al. New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation. J Immunol (2013) 191(8):4020-8. doi:10.4049/jimmunol.1301496
53. Oliveira CC, Querido B, Sluijter M, Derbinski J, van der Burg SH, van Hall T. Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires. Eur J Immunol (2011) 41(11):3114-24. doi:10.1002/eji.201141836
54. Levy M, Futerman AH. Mammalian ceramide synthases. IUBMB Life (2010) 62(5):347-56. doi:10.1002/iub.319
55. Riebeling C, Allegood JC, Wang E, Merrill AH Jr, Futerman AH. Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem (2003) 278(44):43452-9. doi:10.1074/jbc.M307104200
56. Van Hall T, Wolpert EZ, Van Veelen P, Laban S, Van der Veer M, Roseboom M, et al. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med (2006) 12:417-24. doi:10.1038/nm1381
57. Schrul B, Kapp K, Sinning I, Dobberstein B. Signal peptide peptidase (SPP) assembles with substrates and misfolded membrane proteins into distinct oligomeric complexes. Biochem J (2010) 427(3):523-34. doi:10.1042/BJ20091005
58. Loureiro J, Lilley BN, Spooner E, Noriega V, Tortorella D, Ploegh HL. Signal peptide peptidase is required for dislocation from the endoplasmic reticulum. Nature (2006) 441(7095):894-7. doi:10.1038/nature04830
59. van de Weijer ML, Bassik MC, Luteijn RD, Voorburg CM, Lohuis MA, Kremmer E, et al. A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation. Nat Commun (2014) 5:3832. doi:10.1038/ncomms4832
60. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 84(5):769-79. doi:10.1016/S0092-8674(00)81054-5
61. Jeon AH, Bohm C, Chen F, Huo H, Ruan X, Ren CH, et al. Interactome analyses of mature gamma-secretase complexes reveal distinct molecular environments of presenilin (PS) paralogs and preferential binding of signal peptide peptidase to PS2. J Biol Chem (2013) 288(21):15352-66. doi:10.1074/jbc.M112.441840
62. Chapman DC, Williams DB. ER quality control in the biogenesis of MHC class I molecules. Semin Cell Dev Biol (2010) 21(5):512-9. doi:10.1016/j.semcdb.2009.12.013
63. Lilley BN, Ploegh HL. A membrane protein required for dislocation of misfolded proteins from the ER. Nature (2004) 429(6994):834-40. doi:10.1038/nature02592
64. van der Wal FJ, Kikkert M, Wiertz E. The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol. Curr Top Microbiol Immunol (2002) 269:37-55.
65. Chen CY, Malchus NS, Hehn B, Stelzer W, Avci D, Langosch D, et al. Signal peptide peptidase functions in ERAD to cleave the unfolded protein response regulator XBP1u. EMBO J (2014) 33(21):2492-506. doi:10.15252/embj.201488208
66. Bartoszewski R, Brewer JW, Rab A, Crossman DK, Bartoszewska S, Kapoor N, et al. The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. J Biol Chem (2011) 286(48):41862-70. doi:10.1074/jbc.M111.304956
67. de Almeida SF, Fleming JV, Azevedo JE, Carmo-Fonseca M, de Sousa M. Stimulation of an unfolded protein response impairs MHC class I expression. J Immunol (2007) 178(6):3612-9. doi:10.4049/jimmunol.178.6.3612
68. Christianson JC, Olzmann JA, Shaler TA, Sowa ME, Bennett EJ, Richter CM, et al. Defining human ERAD networks through an integrative mapping strategy. Nat Cell Biol (2012) 14(1):93-105. doi:10.1038/ncb2383
69. Snyder HL, Bacik I, Bennink JR, Kearns G, Behrens TW, Bachi T, et al. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J Exp Med (1997) 186(7):1087-98. doi:10.1084/jem.186.7.1087
70. Snyder HL, Bacik I, Yewdell JW, Behrens TW, Bennink JR. Promiscuous liberation of MHC-class I-binding peptides from the C termini of membrane and soluble proteins in the secretory pathway. Eur J Immunol (1998) 28(4):1339-46. doi:10.1002/(SICI)1521-4141(199804)28:04<1339::AID-IMMU1339>3.0.CO;2-B
71. Snyder HL, Yewdell JW, Bennink JR. Trimming of antigenic peptides in an early secretory compartment. J Exp Med (1994) 180(6):2389-94. doi:10.1084/jem.180.6.2389
72. Yewdell JW, Snyder HL, Bacik I, Anton LC, Deng Y, Behrens TW, et al. TAP-independent delivery of antigenic peptides to the endoplasmic reticulum: therapeutic potential and insights into TAP-dependent antigen processing. J Immunother (1998) 21:127-31. doi:10.1097/00002371-199803000-00006
73. Reits E, Griekspoor A, Neijssen J, Groothuis T, Jalink K, van Veelen P, et al. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity (2003) 18(1):97-108. doi:10.1016/S1074-7613(02)00511-3
74. Gil-Torregrosa BC, Raul Castano A, Del Val M. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. J Exp Med (1998) 188(6):1105-16. doi:10.1084/jem.188.6.1105
75. Medina F, Ramos M, Iborra S, de Leon P, Rodriguez-Castro M, Del Val M. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo. J Immunol (2009) 183(7):4639-47. doi:10.4049/jimmunol.0901356
76. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol (2002) 3(10):753-66. doi:10.1038/nrm934
77. Seidah NG, Sadr MS, Chretien M, Mbikay M. The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions. J Biol Chem (2013) 288(30):21473-81. doi:10.1074/jbc.R113.481549
78. Seidah NG, Mayer G, Zaid A, Rousselet E, Nassoury N, Poirier S, et al. The activation and physiological functions of the proprotein convertases. Int J Biochem Cell Biol (2008) 40(6-7):1111-25. doi:10.1016/j.biocel.2008.01.030
79. Susan-Resiga D, Essalmani R, Hamelin J, Asselin MC, Benjannet S, Chamberland A, et al. Furin is the major processing enzyme of the cardiac-specific growth factor bone morphogenetic protein 10. J Biol Chem (2011) 286(26):22785-94. doi:10.1074/jbc.M111.233577
80. Yamada Y, Liu DX. Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells. J Virol (2009) 83(17):8744-58. doi:10.1128/JVI.00613-09
81. Leonhardt RM, Fiegl D, Rufer E, Karger A, Bettin B, Knittler MR. Post-endoplasmic reticulum rescue of unstable MHC class I requires proprotein convertase PC7. J Immunol (2010) 184(6):2985-98. doi:10.4049/jimmunol.0900308
82. Cerundolo V, de la Salle H. Description of HLA class I- and CD8-deficient patients: insights into the function of cytotoxic T lymphocytes and NK cells in host defense. Semin Immunol (2006) 18(6):330-6. doi:10.1016/j.smim.2006.07.006
83. Zimmer J, Andres E, Donato L, Hanau D, Hentges F, de la Salle H. Clinical and immunological aspects of HLA class I deficiency. QJM (2005) 98(10):719-27. doi:10.1093/qjmed/hci112
84. de la Salle H, Houssaint E, Peyrat MA, Arnold D, Salamero J, Pinczon D, et al. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J Immunol (1997) 158(10):4555-63.
85. Aldrich CJ, Ljunggren HG, Van Kaer L, Ashton-Tickardt PG, Tonegawa S, Forman J. Positive selection of self- and alloreactive CD8+ T cells in TAP-1 mutant mice. Proc Natl Acad Sci U S A (1994) 91:6525-8. doi:10.1073/pnas.91.14.6525
86. Sandberg JK, Chambers BJ, Van Kaer L, Karre K, Ljunggren HG. TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity. Eur J Immunol (1996) 26:288-93. doi:10.1002/eji.1830260203
87. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell (1992) 71(7):1205-14. doi:10.1016/S0092-8674(05)80068-6
88. Wolpert EZ, Petersson M, Chambers BJ, Sandberg JK, Kiessling R, Ljunggren HG, et al. Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells. Proc Natl Acad Sci U S A (1997) 94(21):11496-501. doi:10.1073/pnas.94.21.11496
89. Lampen MH, Hassan C, Sluijter M, Geluk A, Dijkman K, Tjon JM, et al. Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2. Mol Immunol (2013) 53(1-2):126-31. doi:10.1016/j.molimm.2012.07.009
90. Lampen MH, Verweij MC, Querido B, van der Burg SH, Wiertz EJ, van Hall T. CD8+ T cell responses against TAP-inhibited cells are readily detected in the human population. J Immunol (2010) 185(11):6508-17. doi:10.4049/jimmunol.1001774
91. Oliveira CC, van Veelen PA, Querido B, de Ru A, Sluijter M, Laban S, et al. The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J Exp Med (2010) 207(1):207-21. doi:10.1084/jem.20091429
92. Nagarajan NA, Gonzalez F, Shastri N. Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol (2012) 13(6):579-86. doi:10.1038/ni.2282
93. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol (2009) 9(12):833-44. doi:10.1038/nri2669
94. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS. Selection of the T cell repertoire. Annu Rev Immunol (1999) 17:829-74. doi:10.1146/annurev.immunol.17.1.829
95. Koble C, Kyewski B. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J Exp Med (2009) 206(7):1505-13. doi:10.1084/jem.20082449
96. El Hage F, Stroobant V, Vergnon I, Baurain JF, Echchakir H, Lazar V, et al. Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway. Proc Natl Acad Sci U S A (2008) 105(29):10119-24. doi:10.1073/pnas.0802753105
97. Durgeau A, El Hage F, Vergnon I, Validire P, de Montpreville V, Besse B, et al. Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTL. J Immunol (2011) 187(11):5532-9. doi:10.4049/jimmunol.1102060
98. Lampen MH, van Hall T. Strategies to counteract MHC-I defects in tumors. Curr Opin Immunol (2011) 23(2):293-8. doi:10.1016/j.coi.2010.12.005
99. Seidel UJ, Oliveira CC, Lampen MH, Hall T. A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens. Cancer Immunol Immunother (2012) 61(1):119-25. doi:10.1007/s00262-011-1160-x
100. Momburg F, Tan P. Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum. Mol Immunol (2002) 39(3-4):217-33. doi:10.1016/S0161-5890(02)00103-7
101. Garstka MA, Fish A, Celie PH, Joosten RP, Janssen GM, Berlin I, et al. The first step of peptide selection in antigen presentation by MHC class I molecules. Proc Natl Acad Sci U S A (2015) 112(5):1505-10. doi:10.1073/pnas.1416543112
102. Weinzierl AO, Rudolf D, Hillen N, Tenzer S, van Endert P, Schild H, et al. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry. Eur J Immunol (2008) 38(6):1503-10. doi:10.1002/eji.200838136
103. Wearsch PA, Cresswell P. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol (2007) 8(8):873-81. doi:10.1038/ni1485
104. Song R, Porgador A, Harding CV. Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens. Immunology (1999) 97(2):316-24. doi:10.1046/j.1365-2567.1999.00759.x
105. Spee P, Neefjes J. TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin. Eur J Immunol (1997) 27(9):2441-9. doi:10.1002/eji.1830270944
106. Hermann C, Strittmatter LM, Deane JE, Boyle LH. The binding of TAPBPR and tapasin to MHC class I is mutually exclusive. J Immunol (2013) 191(11):5743-50. doi:10.4049/jimmunol.1300929
107. Lautscham G, Mayrhofer S, Taylor G, Haigh T, Leese A, Rickinson A, et al. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. J Exp Med (2001) 194(8):1053-68. doi:10.1084/jem.194.8.1053
108. Tey SK, Khanna R. Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway. Blood (2012) 120(5):994-1004. doi:10.1182/blood-2012-01-402404
109. Chemali M, Radtke K, Desjardins M, English L. Alternative pathways for MHC class I presentation: a new function for autophagy. Cell Mol Life Sci (2011) 68(9):1533-41. doi:10.1007/s00018-011-0660-3
110. English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D, et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol (2009) 10(5):480-7. doi:10.1038/ni.1720
111. Crotzer VL, Blum JS. Autophagy and adaptive immunity. Immunology (2010) 131(1):9-17. doi:10.1111/j.1365-2567.2010.03321.x
112. Kim HJ, Lee S, Jung JU. When autophagy meets viruses: a double-edged sword with functions in defense and offense. Semin Immunopathol (2010) 32(4):323-41. doi:10.1007/s00281-010-0226-8
113. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol (2007) 7(10):767-77. doi:10.1038/nri2161
114. Munz C. Autophagy and antigen presentation. Cell Microbiol (2006) 8(6):891-8. doi:10.1111/j.1462-5822.2006.00714.x
115. Mijaljica D, Prescott M, Devenish RJ. Endoplasmic reticulum and Golgi complex: contributions to, and turnover by, autophagy. Traffic (2006) 7(12):1590-5. doi:10.1111/j.1600-0854.2006.00495.x
116. Yorimitsu T, Klionsky DJ. Eating the endoplasmic reticulum: quality control by autophagy. Trends Cell Biol (2007) 17(6):279-85. doi:10.1016/j.tcb.2007.04.005
117. Del Val M, Iborra S, Ramos M, Lazaro S. Generation of MHC class I ligands in the secretory and vesicular pathways. Cell Mol Life Sci (2011) 68(9):1543-52. doi:10.1007/s00018-011-0661-2
118. Jahreiss L, Menzies FM, Rubinsztein DC. The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes. Traffic (2008) 9(4):574-87. doi:10.1111/j.1600-0854.2008.00701.x
119. Oliveira CC, Sluijter M, Querido B, Ossendorp F, van der Burg SH, van Hall T. Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire. Mol Immunol (2014) 62(1):129-36. doi:10.1016/j.molimm.2014.06.006
120. Lorente E, Garcia R, Lopez D. Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells. J Biol Chem (2011) 286(44):38054-9. doi:10.1074/jbc.M111.281808
121. Lorente E, Infantes S, Barnea E, Beer I, Barriga A, Garcia-Medel N, et al. Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells. PLoS One (2013) 8(3):e59118. doi:10.1371/journal.pone.0059118
122. Tiwari N, Garbi N, Reinheckel T, Moldenhauer G, Hammerling GJ, Momburg F. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. J Immunol (2007) 178(12):7932-42. doi:10.4049/jimmunol.178.12.7932